BMJ Best Practice

参考文献

关键文献

Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt). 2010;11:79-109.

Kaplan GG, Gregson DB, Laupland KB. Population-based study of the epidemiology of and the risk factors for pyogenic liver abscess. Clin Gastroenterol Hepatol. 2004;2:1032-1038.

Pieracci FM, Barie PS. Intra-abdominal infections. Curr Opin Crit Care. 2007;13:440-449.

Wong PF, Gilliam AD, Kumar S, et al. Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults. Cochrane Database Syst Rev. 2005;(2):CD004539.

参考文章

1.  Otagiri N, Soeda J, Yoshino T, et al. Primary abscess of the omentum: report of a case. Surg Today. 2004;34:261-264.

2.  Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt). 2010;11:79-109.

3.  Margalit M, Elinav H, Ilan Y, et al. Liver abscess in inflammatory bowel disease: report of two cases and review of the literature. J Gastroenterol Hepatol. 2004;19:1338-1342.

4.  Usdan LS, Massinople C. Multiple pyogenic liver abscesses associated with occult appendicitis and possible Crohn's disease. Tenn Med. 2002;95:463-464.

5.  Fry DE, Garrison RN, Heitsch RC, et al. Determinants of death in patients with intraabdominal abscess. Surgery. 1980;88:517-523.

6.  Lagana D, Carrafiello G, Mangini M, et al. Image-guided percutaneous treatment of abdominal-pelvic abscesses: a 5-year experience. Radiol Med. 2008;113:999-1007.

7.  Lawson EH1, Ko CY, Adams JL, et al. Reliability of evaluating hospital quality by colorectal surgical site infection type. Ann Surg. 2013;258:994-1000.

8.  Altemeier WA, Culbertson WR, Fullen WD, et al. Intra-abdominal abscesses. Am J Surg. 1973;125:70-79.

9.  Kumar RR, Kim JT, Haukoos JS, et al. Factors affecting the successful management of intra-abdominal abscesses with antibiotics and the need for percutaneous drainage. Dis Colon Rectum. 2006;49:183-189.

10.  Berger D, Buttenschoen K. Management of abdominal sepsis. Langenbecks Arch Surg. 1998;383:35-43.

11.  Sirinek KR. Diagnosis and treatment of intra-abdominal abscesses. Surg Infect (Larchmt). 2000;1:31-38.

12.  Malangoni MA. Pathogenesis and treatment of intra-abdominal infection. Surg Gynecol Obstet. 1990;171(suppl):S31-S34.

13.  Hau T, Jacobs DE, Hawkins NL. Antibiotics fail to prevent abscess formation secondary to bacteria trapped in fibrin clots. Arch Surg. 1986;121:163-168.

14.  Thomsen RW, Jepsen P, Sørensen HT. Diabetes mellitus and pyogenic liver abscess: risk and prognosis. Clin Infect Dis. 2007;44:1194-1201.

15.  Tsai FC, Huang YT, Chang LY, et al. Pyogenic liver abscess as endemic disease, Taiwan. Emerg Infect Dis. 2008;14:1592-1600.

16.  Damrauer SM, Bordeianou L, Berger D. Contained anastomotic leaks after colorectal surgery: are we too slow to act? Arch Surg. 2009;144:333-338.

17.  Kaplan GG, Gregson DB, Laupland KB. Population-based study of the epidemiology of and the risk factors for pyogenic liver abscess. Clin Gastroenterol Hepatol. 2004;2:1032-1038.

18.  Rahimian J, Wilson T, Oram V, et al. Pyogenic liver abscess: recent trends in etiology and mortality. Clin Infect Dis. 2004;39:1654-1659.

19.  Brueggemeyer MT, Saba AK, Thibodeaux LC. Abscess formation following spilled gallstones during laparoscopic cholecystectomy. JSLS. 1997;1:145-152.

20.  Tomita H, Osada S, Miya K, et al. Delayed recurrence of postoperative intra-abdominal abscess: an unusual case and review of the literature. Surg Infect (Larchmt). 2006;7:551-554.

21.  Panés J, Bouzas R, Chaparro M, et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease. Aliment Pharmacol Ther. 2011;34:125-145.

22.  Knochel JQ, Koehler PR, Lee TG, et al. Diagnosis of abdominal abscesses with computed tomography, ultrasound, and 111In leukocyte scans. Radiology. 1980;137:425-432.

23.  American College of Radiology. ACR appropriateness criteria: acute (nonlocalized) abdominal pain and fever or suspected abdominal abscess. 2012. http://www.acr.org/ (last accessed 14 September 2017).

24.  Prasad GA, Varadarajulu S. Endoscopic ultrasound-guided abscess drainage. Gastrointest Endosc Clin N Am. 2012;22:281-290.

25.  Men S, Akhan O, Koroglu M. Percutaneous drainage of abdominal abcess. Eur J Radiol. 2002;43:204-218.

26.  Oto A, Ernst RD, Ghulmiyyah LM, et al. MR imaging in the triage of pregnant patients with acute abdominal and pelvic pain. Abdom Imaging. 2009;34:243-250.

27.  Barie PS, Williams MD, McCollam JS, et al; PROWESS Surgical Evaluation Committee. Benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis. Am J Surg. 2004;188:212-220.

28.  Pieracci FM, Barie PS. Intra-abdominal infections. Curr Opin Crit Care. 2007;13:440-449.

29.  American College of Radiology. ACR appropriateness criteria: radiologic management of infected fluid collections. 2014. http://www.acr.org/ (last accessed 14 September 2017).

30.  Andersen JC, Bundgaard L, Elbrønd H, et al; Danish Surgical Society. Danish national guidelines for treatment of diverticular disease. Dan Med J. 2012;59:C4453.

31.  Cinat ME, Wilson SE, Din AM. Determinants for successful percutaneous image-guided drainage of intra-abdominal abscess. Arch Surg. 2002;137:845-849.

32.  Feagins LA, Holubar SD, Kane SV, et al. Current strategies in the management of intra-abdominal abscesses in Crohn's disease. Clin Gastroenterol Hepatol. 2011;9:842-850.

33.  Oberkofler CE, Rickenbacher A, Raptis DA, et al. A multicenter randomized clinical trial of primary anastomosis or Hartmann's procedure for perforated left colonic diverticulitis with purulent or fecal peritonitis. Ann Surg. 2012;256:819-826.

34.  Angenete E, Thornell A, Burcharth J, et al. Laparoscopic lavage is feasible and safe for the treatment of perforated diverticulitis with purulent peritonitis: the first results from the randomized controlled trial DILALA. Ann Surg. 2016;263:117-122.

35.  Schultz JK, Yaqub S, Wallon C, et al. Laparoscopic lavage vs primary resection for acute perforated diverticulitis: the SCANDIV randomized clinical trial. JAMA. 2015;314:1364-1375.

36.  Thornell A, Angenete E, Bisgaard T, et al. Laparoscopic lavage for perforated diverticulitis with purulent peritonitis: a randomized trial. Ann Intern Med. 2016;164:137-145.

37.  Hedrick TL, Sawyer RG, Foley EF, et al. Anastomotic leak and the loop ileostomy: friend or foe? Dis Colon Rectum. 2006;49:1167-1176.

38.  National Institute for Health and Care Excellence. Negative pressure wound therapy for the open abdomen. November 2013. http://www.nice.org.uk/ (last accessed 14 September 2017).

39.  Aydin C, Piskin T, Sumer F, et al. Laparoscopic drainage of pyogenic liver abscess. JSLS. 2010;14(3):418-420.

40.  Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589-1596.

41.  Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165-228.

42.  Mazuski JE, Sawyer RG, Nathens AB, et al. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations. Surg Infect (Larchmt). 2002;3:175-233.

43.  Solomkin JS, Mazuski JE, Baron EJ, et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis. 2003;37:997-1005.

44.  Wong PF, Gilliam AD, Kumar S, et al. Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults. Cochrane Database Syst Rev. 2005;(2):CD004539.

45.  Birmingham MC, Rayner CR, Meagher AK, et al. Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. Clin Infect Dis. 2003;36:159-168.

46.  Rivera AM, Boucher HW. Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci. Mayo Clin Proc. 2011;86:1230-1243.

47.  Rubinstein E, Keynan Y. Vancomycin-resistant enterococci. Crit Care Clin. 2013;29:841-852.

48.  Delgado-Valverde M, Sojo-Dorado J, Pascual A, et al. Clinical management of infections caused by multi-drug resistant Enterobacteriaceae. Ther Adv Infect Dis. 2013;1:49-69.

49.  Zhanel GG, Lawson CD, Adam H, et al. Ceftazidime-avibactam: a novel cephalosporin/beta-lactamase inhibitor combination. Drugs. 2013;73:159-177.

50.  Pitart C, Marco F, Keating TA, et al. Evaluation of the activity of ceftazidime-avibactam against fluoroquinolone-resistant Enterobacteriaceae and Pseudomonas. Antimicrob Agents Chemother. 2015;59:3059-3065.

51.  Sawyer RG, Claridge JA, Nathens AB, et al. Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med. 2015;372:1996-2005.

52.  Solomkin J, Hershberger E, Miller B, et al. Ceftolozane/tazobactam plus metronidazole for complicated intra-abdominal infections in an era of multidrug resistance: results from a randomized, double-blind, phase 3 trial (ASPECT-cIAI). Clin Infect Dis. 2015;60:1462-1471.

53.  Bare M, Castells X, Garcia A, et al. Importance of appropriateness of empiric antibiotic therapy on clinical outcomes in intra-abdominal infections. Int J Technol Assess Health Care. 2006;22:242-248.

使用此内容应接受我们的免责声明